C. Blake Gilks - Concepedia

Author

C. Blake Gilks

Also Known As

C B Gilks, C Blake Gilks, C Gilks, C. B. Gilks, C. Blake Gilks, C.B. Gilks, C.Blake Gilks, CB Gilks, Gilks, C. Blake, Jason Li

228

Publications

23.5K

Citations

H-Index

147

Concepts

All Affiliations

University of British Columbia Vancouver General Hospital BC Cancer Agency University of Calgary University of Toronto

About

C. Blake Gilks is an author at University of British Columbia specializing in medicine, pathology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	55	89	10.1K
2	Public Health	9	9	693
3	Engineering	7	7	832
4	Health Sciences	2	2	141
5	Natural Sciences	1	1	152

C. Blake Gilks

165

Publications

21.4K

Citations

H-Index

Page 1

	Year	Citations
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma Torsten O. Nielsen, Forrest D. Hsu, Kristin C. Jensen, Clinical Cancer Research	2004	2.6K
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells Andrea Facciabene, Xiaohui Peng, Ian S. Hagemann, Nature Tumor BiologyAngiogenesisImmunologyCell ProliferationVascular Biology	2011	1.3K
Mutation of <i>FOXL2</i> in Granulosa-Cell Tumors of the Ovary Sohrab P. Shah, Martin Köbel, Janine Senz, New England Journal of Medicine	2009	756
Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series Stefan Kommoss, Melissa K. McConechy, F. Kommoss, Annals of Oncology	2018	712
Cancer-Associated Mutations in Endometriosis without Cancer Michael S. Anglesio, Nickolas Papadopoulos, A. Ayhan, New England Journal of Medicine	2017	590
A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells Robert B. West, Brian P. Rubin, Melinda A. Miller, Proceedings of the National Academy of Sciences Tumoral PathologyTenosynovial Giant-cell TumorMalignant DiseaseMedicineImmunology	2006	547
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors Katy Milne, Martin Köbel, Steven E. Kalloger, PLoS ONE	2009	430
TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data Gavin Ha, Andrew Roth, Jaswinder Khattra, Genome Research Clonal Cell PopulationsEngineeringCopy Number ArchitecturesGeneticsGenomics	2014	415
Integrated genomic characterization of endometrial carcinoma Gad Getz, Stacey Gabriel, Kristian Cibulskis, Carolina Digital Repository (University of North Carolina at Chapel Hill)	2013	414
Differences in Tumor Type in Low-stage Versus High-stage Ovarian Carcinomas Martin Köbel, Steve E. Kalloger, David G. Huntsman, International Journal of Gynecological Pathology Tumoral PathologyGynecological SurgeryOvarian CarcinomasMedicineTumor Type	2010	395

Page 1